[Clinical, clinical-chemical and cerebral bioelectric testing of a combination of hexobendine, ethamivan and hydroxyethyltheophyllin].
D000200:Action Potentials / Q000187:drug effects*; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001549:Benzamides / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D001797:Blood Protein Electrophoresis; D002118:Calcium / Q000097:blood; D002396:Catechols / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003864:Depression, Chemical; D004569:Electroencephalography; D004906:Erythrocyte Count; D005029:Ethylenediamines / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D008111:Liver Function Tests; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013806:Theophylline / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001549:Benzamides; D001565:Benzoates; D001786:Blood Glucose; D002396:Catechols; D000697:Central Nervous System Stimulants; D005029:Ethylenediamines; D006454:Hemoglobins; D014665:Vasodilator Agents; D012964:Sodium; D013806:Theophylline; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D011188:Potassium; D002118:Calcium
Klinische, klinisch-chemische und hirnbioelektrische Prüfung einer Kombination aus Hexobendin, Etamivan und Hydroxyäthyltheophyllin.